The CD8β polypeptide is required for the recognition of an altered peptide ligand as an agonist
- 1 December 1996
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (12) , 2999-3007
- https://doi.org/10.1002/eji.1830261227
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.Proceedings of the National Academy of Sciences, 1995
- ζ Phosphorylation Without ZAP-70 Activation Induced by TCR Antagonists or Partial AgonistsScience, 1995
- T cell receptor antagonists and partial agonistsImmunity, 1995
- Partial T cell signaling: Altered phospho-? and lack of zap70 recruitment in APL-induced T cell anergyCell, 1994
- Specificity and flexibility in thymic selectionNature, 1994
- Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells.The Journal of Experimental Medicine, 1993
- Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptorCell, 1992
- Separation of IL-4 Production from Th Cell Proliferation by an Altered T Cell Receptor LigandScience, 1991
- Molecular Interactions, T‐Cell Subsets and a Role of the CD4/CD8:p56lck Complex in Human T‐Cell ActivationImmunological Reviews, 1989
- The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lckCell, 1988